e-learning
resources
Barcelona 2010
Tuesday, 21.09.2010
From rare towards common lung diseases: diagnostic and monitoring challenges
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Late Breaking Abstract: Angiotensin II receptor blocker is associated with lower mortality in hospitalized patients with pneumonia
M. I. Restrepo, L. Copeland, M. J. Pugh, A. Anzueto, E. M. Mortensen (San Antonio, United States Of America)
Source:
Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Session:
From rare towards common lung diseases: diagnostic and monitoring challenges
Session type:
Thematic Poster Session
Number:
4614
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. I. Restrepo, L. Copeland, M. J. Pugh, A. Anzueto, E. M. Mortensen (San Antonio, United States Of America). Late Breaking Abstract: Angiotensin II receptor blocker is associated with lower mortality in hospitalized patients with pneumonia. Eur Respir J 2010; 36: Suppl. 54, 4614
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effect of angiotensin II receptor antagonists on cardiovascular disorders in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 212s
Year: 2001
Prior use of both a statin and ARB is associated with lower mortality for patients hospitalized with pneumonia
Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies
Year: 2016
Late Breaking Abstract - The neurokinin-1 receptor antagonist orvepitant improves chronic cough symptoms: results from a Phase 2b trial
Source: International Congress 2019 – Highlights in lung function and chronic cough
Year: 2019
Late Breaking Abstract - Pneumonectomy in patients with reduced pulmonary function: complications and 30-day mortality
Source: International Congress 2019 – General thoracic surgery
Year: 2019
LATE-BREAKING ABSTRACT: Angiotensin II receptor 1 blocker (Losartan) restores the ability of the lung to clear edema in rats.
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Impact of blockers of AT1 receptors to angiotensin II on endothelium vasoregulating function in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 739s
Year: 2006
Late Breaking Abstract - Calcium-sensing receptor activators increased in the sputum of idiopathic pulmonary fibrosis patients
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019
Cardiohemodynamics changes in COPD patients while using blockers of AT1 receptors to angiotensin II
Source: Eur Respir J 2006; 28: Suppl. 50, 105s
Year: 2006
Evaluation in administration of angiotensin II receptor antagonist Valsartan in the treatment of hypertension patients with chronic obstructive pulmonary disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Severe pneumonia mortality in pediatric patients is associated with downregulation of Toll-like receptors 2 and 4 on monocytes
Source: International Congress 2016 – Neonatal and paediatric multiorgan manifestations of acute and chronic pulmonary disease and use of treatments
Year: 2016
Late Breaking Abstract - Inhaled corticosteroids in bronchiectasis is associated to increased morbidity, Pseudomonas colonization and mortality – a five-year prospective cohort study
Source: Virtual Congress 2020 – Scientific advances in airway pharmacology
Year: 2020
Association of outpatient statin, ARB, and ACE inhibitor use on clinical outcomes for elderly subjects hospitalized with severe sepsis
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Late Breaking Abstract - Corticosteroids reduce mortality and prevent ICU admission in Covid-19 pneumonia – results from a rapid clinical review of 191 patients
Source: Virtual Congress 2020 – COVID-19 clinical studies
Year: 2020
Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Why low risk class CURB patients with CAP are hospitalized?
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Angiotensin II receptor blockers, ACE inhibitors, lung function and percent emphysema; the MESA lung study
Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities
Year: 2012
Inpatients with PSI III community-acquired pneumonia: are low or high risk patients?
Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia
Year: 2007
Late Breaking Abstract - Transient Receptor Potential Vanilloid subtype 4 in patients with lung cancer
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
Late Breaking Abstract - CPAP is effective in treating COVID-19 patients with Type 1 respiratory failure.
Source: Virtual Congress 2020 – Nasal high flow and non-invasive ventilation in acute and chronic care
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept